- Report
- April 2023
- 80 Pages
Asia Pacific
From €4160EUR$4,750USD£3,611GBP
Fospropofol is an anesthetic drug used in the induction and maintenance of general anesthesia. It is a prodrug of propofol, a sedative-hypnotic agent used for the induction and maintenance of general anesthesia. Fospropofol is a water-soluble, lipid-soluble, and rapidly metabolized prodrug of propofol. It is administered intravenously and is metabolized by the liver to propofol, which is then metabolized by the body. Fospropofol is used in the induction and maintenance of general anesthesia, as well as in the treatment of status epilepticus. It is also used in the treatment of refractory seizures and in the management of acute agitation. Fospropofol has a rapid onset of action and a short duration of action, making it an ideal agent for the induction and maintenance of general anesthesia.
Some companies in the Fospropofol market include Fresenius Kabi, Hospira, Mylan, and Teva Pharmaceuticals. Show Less Read more